Literature DB >> 23137055

The impacts of AIDS movements on the policy responses to HIV/AIDS in Brazil and South Africa: a comparative analysis.

Amy Nunn1, Samuel Dickman, Nicoli Nattrass, Alexandra Cornwall, Sofia Gruskin.   

Abstract

Brazil and South Africa were among the first countries profoundly impacted by the HIV/AIDS epidemic and had similar rates of HIV infection in the early 1990s. Today, Brazil has less than 1% adult HIV prevalence, implemented treatment and prevention programmes early in the epidemic, and now has exemplary HIV/AIDS programmes. South Africa, by contrast, has HIV prevalence of 18% and was, until recently, infamous for its delayed and inappropriate response to the HIV/AIDS epidemic. This article explores how differing relationships between AIDS movements and governments have impacted the evolving policy responses to the AIDS epidemic in both countries, including through AIDS programme finance, leadership and industrial policy related to production of generic medicines.

Entities:  

Mesh:

Year:  2012        PMID: 23137055      PMCID: PMC3738204          DOI: 10.1080/17441692.2012.736681

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  23 in total

1.  Dramatic improvement in survival among adult Brazilian AIDS patients.

Authors:  Jose Ricardo P Marins; Leda F Jamal; Sanny Y Chen; Marilisa B Barros; Esther S Hudes; Aristides A Barbosa; Pedro Chequer; Paulo R Teixeira; Norman Hearst
Journal:  AIDS       Date:  2003-07-25       Impact factor: 4.177

2.  Magnitude and trend of the AIDS epidemic in Brazilian cities, from 2002 to 2006.

Authors:  Alexandre Grangeiro; Maria Mercedes Loureiro Escuder; Euclides Ayres Castilho
Journal:  Rev Saude Publica       Date:  2010-05-14       Impact factor: 2.106

3.  HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.

Authors:  Jon Cohen
Journal:  Science       Date:  2006-07-28       Impact factor: 47.728

4.  [The AIDS epidemic in Brazil and differences according to geographic region and health services supply].

Authors:  Alexandre Grangeiro; Maria Mercedes Loureiro Escuder; Euclides Ayres de Castilho
Journal:  Cad Saude Publica       Date:  2010-12       Impact factor: 1.632

5.  The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa.

Authors:  Nicoli Nattrass; Nathan Geffen
Journal:  Afr J AIDS Res       Date:  2005-05       Impact factor: 1.300

6.  South Africa's "rollout" of highly active antiretroviral therapy: a critical assessment.

Authors:  Nicoli Nattrass
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-15       Impact factor: 3.731

7.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

Review 8.  Brazil and access to HIV/AIDS drugs: a question of human rights and public health.

Authors:  Jane Galvão
Journal:  Am J Public Health       Date:  2005-06-02       Impact factor: 9.308

9.  AIDS treatment in Brazil: impacts and challenges.

Authors:  Amy Stewart Nunn; Elize Massard da Fonseca; Francisco I Bastos; Sofia Gruskin
Journal:  Health Aff (Millwood)       Date:  2009 Jul-Aug       Impact factor: 6.301

10.  Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.

Authors:  Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

View more
  9 in total

1.  Emergence of universal antiretroviral therapy coverage in South Africa: applying the advocacy coalition framework to refine the narratives and inform epidemic responses.

Authors:  Benjamin Momo Kadia; Christian Akem Dimala; Kevin Pene Njefi
Journal:  Pan Afr Med J       Date:  2022-05-05

2.  PrEP Implementation Science: State-of-the-Art and Research Agenda.

Authors:  Carlos F Cáceres; Kenneth H Mayer; Rachel Baggaley; Kevin R O'Reilly
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

3.  Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges.

Authors:  Valdilea G Veloso; Fabio Mesquita; Beatriz Grinsztejn
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

4.  State-civil society partnerships for HIV/AIDS treatment and prevention in Ghana: exploring factors associated with successes and challenges.

Authors:  Martin Hushie; Cephas N Omenyo; Jacob J van den Berg; Michelle A Lally
Journal:  BMC Health Serv Res       Date:  2016-08-02       Impact factor: 2.655

5.  Monitoring HIV and AIDS Related Policy Reforms: A Road Map to Strengthen Policy Monitoring and Implementation in PEPFAR Partner Countries.

Authors:  Jeffrey Lane; Andre Verani; Mai Hijazi; Erin Hurley; Amy Hagopian; Nicole Judice; Ron MacInnis; Sallie Sanford; Sarah Zelek; Aaron Katz
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

6.  Understanding how domestic health policy is integrated into foreign policy in South Africa: a case for accelerating access to antiretroviral medicines.

Authors:  Simon Moeketsi Modisenyane; Stephen James Heinrich Hendricks; Harvey Fineberg
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

7.  UNICEF's contribution to the adoption and implementation of option B+ for preventing mother-to-child transmission of HIV: a policy analysis.

Authors:  M F Chersich; E Newbatt; K Ng'oma; I de Zoysa
Journal:  Global Health       Date:  2018-06-01       Impact factor: 4.185

Review 8.  Engaging globally with how to achieve healthy societies: insights from India, Latin America and East and Southern Africa.

Authors:  Rene Loewenson; Eugenio Villar; Rama Baru; Robert Marten
Journal:  BMJ Glob Health       Date:  2021-04

9.  Expanding the Debate: Citizen Participation for the Implementation of the Right to Health in Brazil.

Authors:  Regiane Garcia
Journal:  Health Hum Rights       Date:  2018-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.